← Back to patent-cliff list
Olgotrelvir
Tier C — Watch / tradeOlgotrelvir
Texas A&M University
Originator
2025
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：3CLp, CTSL
Brand：Ovydso
Indications (approved)：COVID-19
Regional status
US
Phase I
2022-07-19
EU
-
China
Approved
2025-10-28
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Olgotrelvir?
Approved indications include: COVID-19.
When does the Olgotrelvir patent expire?
No public expiry year is available for Olgotrelvir yet; this page updates once verified.
How do I get a quote for Olgotrelvir intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01